Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Predicting Impact of DNA and RNA Variants in Cancer on Three Dimensional Protein Structure

FY 2015-16

Summary
Cancer is fundamentally a genomic disease - caused by variations in our genetic makeup resulting in rapidly dividing cells. Large scale efforts have been made to define the mutations causing cancer's characteristic dysregulation of cell growth, however, understanding the etiology and progression of cancer requires understanding the impact of these mutations. As the Central Dogma of Biology outlines, mutations in DNA are transcribed into RNA and RNA is further translated into proteins where they can impact normal cellular functioning. Therefore, elucidating the mechanisms by which mutations in both DNA and RNA affect the functionality of downstream proteins is essential in understanding both the cause and progression of cancer. Given the strong link between protein structure and function, the change in a protein's functionality can be determined by understanding the change in its structure. My project aims to fill the current gap between mutation detection and impact by developing an open-source state-of-the-art computational tool to predict the three dimensional change in protein structure resulting from DNA and RNA variants. This tool will allow for insight into the consequence of mutations commonly associated with cancer as well as advance the development of biomarkers. Currently, biomarkers are based solely on the presence of specific mutations, which inaccurately assumes equivalence of all mutations. Instead, this tool will allow for the development of biomarkers based on mutational impact resulting in more robust and effective biomarkers.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
350049
Name
Houlahan Kathleen E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predicting Impact of DNA and RNA Variants in Cancer on Three Dimensional Protein Structure
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Biomarkers; Cancer; Machine Learning; Mutational Impact; Mutations; Protein Structure Prediction; Splice Variants; Tool Development
Abstract
Cancer is fundamentally a genomic disease - caused by variations in our genetic makeup resulting in rapidly dividing cells. Large scale efforts have been made to define the mutations causing cancer's characteristic dysregulation of cell growth, however, understanding the etiology and progression of cancer requires understanding the impact of these mutations. As the Central Dogma of Biology outlines, mutations in DNA are transcribed into RNA and RNA is further translated into proteins where they can impact normal cellular functioning. Therefore, elucidating the mechanisms by which mutations in both DNA and RNA affect the functionality of downstream proteins is essential in understanding both the cause and progression of cancer. Given the strong link between protein structure and function, the change in a protein's functionality can be determined by understanding the change in its structure. My project aims to fill the current gap between mutation detection and impact by developing an open-source state-of-the-art computational tool to predict the three dimensional change in protein structure resulting from DNA and RNA variants. This tool will allow for insight into the consequence of mutations commonly associated with cancer as well as advance the development of biomarkers. Currently, biomarkers are based solely on the presence of specific mutations, which inaccurately assumes equivalence of all mutations. Instead, this tool will allow for the development of biomarkers based on mutational impact resulting in more robust and effective biomarkers.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Houlahan, Kathleen E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~